Carlson Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,770
Closed -$221K 118
2023
Q4
$221K Sell
2,770
-180
-6% -$13.5K 0.01% 191
2023
Q3
$210K Buy
2,950
+50
+2% +$3.74K 0.01% 163
2023
Q2
$223K Hold
2,900
0.01% 153
2023
Q1
$218K Sell
2,900
-31
-1% -$2.31K 0.01% 154
2022
Q4
$231K Buy
+2,931
New +$220K 0.02% 150
2022
Q3
Sell
-2,517
Closed -$202K 163
2022
Q2
$202K Buy
+2,517
New +$197K 0.02% 154
2022
Q1
Sell
-2,479
Closed -$212K 174
2021
Q4
$212K Buy
+2,479
New +$194K 0.02% 159

Other funds holding CL

Carlson Capital Management's CL Position: Q1 2024 in Review

Carlson Capital Management sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 2,770 shares — an estimated $221K sold.

Carlson Capital Management first reported a position in CL in Q4 2021 and held it in 7 quarters. The position peaked at $231K in Q4 2022. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

  • Carlson Capital Management reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
  • Carlson Capital Management sold 2,770 Colgate-Palmolive shares in Q1 2024, an estimated $221K.
  • Carlson Capital Management first reported a position in Colgate-Palmolive in Q4 2021 and held it in 7 quarters.
  • Carlson Capital Management's Colgate-Palmolive position peaked at $231K in Q4 2022.
  • 1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Carlson Capital Management's 13F filing for Q1 2024, filed 12 Apr 2024.